Formerly dba as Endls Optics, Zenalux Biomedical is developing novel biophotonic-based tools to aid in the diagnosis and treatment of cancer as well as other disease states. The companyâs flagship product is the Zenascope, a patent-protected, photonic system that non-destructively measures dominant tissue chromophores (oxygenated hemoglobin, deoxygenated hemoglobin and beta-carotene) as well as changes in cellular morphology and density. An organizing princple of the firm is to make optical spectroscopy easy for medical practitioners who are interested in real-time, non-destructive biological tissue diagnostics. The firm's products provide effortless translation of uv-vis tissue spectra into quantified biological endpoints to enable the medical professional to focus on medical applications of the technology.
